4D Pharma shares surge on positive clinical results for cancer drug
Shares in live biotherapeutics company 4D Pharma (DDDD:AIM) surged 33% to 104p on Wednesday after the release of highly encouraging clinical results in the first part of a trial aimed at treating patients with advanced kidney...
26 August 2020